Akihiro Yanagita
Chugai Pharmaceutical Co., Ltd.
Appearances
DateDecember 7, 2021Continuous Manufacturing (CM) of biologics has been a hot topic for recent years because it has a potential for improving the efficiency, agility, and flexibility of drug substance and drug product manufacturing…Session Chairs
BioMarin Pharmaceutical Inc.PMDA-Pharmaceuticals and Medical Devices AgencySpeakers
PMDA-Pharmaceuticals and Medical Devices AgencyPMDA-Pharmaceuticals and Medical Devices AgencySanofiPanel Members
Merck & Co., Inc.Novo Nordisk Inc.Chugai Pharmaceutical Co., Ltd.
DateDecember 7, 2021Continuous Manufacturing (CM) of biologics has been a hot topic for recent years because it has a potential for improving the efficiency, agility, and flexibility of drug substance and drug product manufacturing…Session Chairs
BioMarin Pharmaceutical Inc.PMDA-Pharmaceuticals and Medical Devices AgencySpeakers
PMDA-Pharmaceuticals and Medical Devices AgencyPMDA-Pharmaceuticals and Medical Devices AgencySanofiPanel Members
Merck & Co., Inc.Novo Nordisk Inc.Chugai Pharmaceutical Co., Ltd.
